Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Leibovici

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Immunotherapy|November 8, 2011
The tumor microenvironment: part 1Judith Leibovici, Orit Itzhaki, Monica Huszar, et al.
Immunotherapy|November 8, 2011
Targeting the tumor microenvironment by immunotherapy: part 2Judith Leibovici, Orit Itzhaki, Monica Huszar, et al.
Mechanisms of Ageing and Development|December 9, 2003
Ageing-apoptosis relation in murine spleenOrit Itzhaki, Ehud Skutelsky, Tatiana Kaptzan, et al.
Experimental Gerontology|July 9, 2004
Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strainsTanya Kaptzan, Ehud Skutelsky, Orit Itzhaki, et al.
Experimental Gerontology|February 12, 2008
Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged miceOrit Itzhaki, Ehud Skutelsky, Tatiana Kaptzan, et al.
Mechanisms of Ageing and Development|May 6, 2008
Designing ageing conditions in tumour microenvironment-a new possible modality for cancer treatmentJudith Leibovici, Orit Itzhaki, Tatiana Kaptzan, et al.
Biochimica Et Biophysica Acta|March 3, 2004
Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the agedOrit Itzhaki, Tatiana Kaptzan, Ehud Skutelsky, et al.
Mechanisms of Ageing and Development|February 16, 2006
Efficacy of anti-angiogenic treatment of tumors in old versus young miceTatiana Kaptzan, Ehud Skutelsky, Orit Itzhaki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Immunotherapy|November 8, 2011
The tumor microenvironment: part 1Judith Leibovici, Orit Itzhaki, Monica Huszar, et al.
Immunotherapy|November 8, 2011
Targeting the tumor microenvironment by immunotherapy: part 2Judith Leibovici, Orit Itzhaki, Monica Huszar, et al.
Mechanisms of Ageing and Development|December 9, 2003
Ageing-apoptosis relation in murine spleenOrit Itzhaki, Ehud Skutelsky, Tatiana Kaptzan, et al.
Experimental Gerontology|July 9, 2004
Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strainsTanya Kaptzan, Ehud Skutelsky, Orit Itzhaki, et al.
Experimental Gerontology|February 12, 2008
Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged miceOrit Itzhaki, Ehud Skutelsky, Tatiana Kaptzan, et al.
Mechanisms of Ageing and Development|May 6, 2008
Designing ageing conditions in tumour microenvironment-a new possible modality for cancer treatmentJudith Leibovici, Orit Itzhaki, Tatiana Kaptzan, et al.
Biochimica Et Biophysica Acta|March 3, 2004
Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the agedOrit Itzhaki, Tatiana Kaptzan, Ehud Skutelsky, et al.
Mechanisms of Ageing and Development|February 16, 2006
Efficacy of anti-angiogenic treatment of tumors in old versus young miceTatiana Kaptzan, Ehud Skutelsky, Orit Itzhaki, et al.
Pageof 1